Trial Profile
A study investigating safety and efficacy of Dimethyl-fumarate in patients with relapsing-remitting multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 27 Feb 2016 New trial record